Like imorphics

closed 2/11/2016 via BNC Analysis

Stryker Corporation, acquired imorphics

See 991 Comparable Transactions
synopsis: Stryker Corporation has acquired Imorphics, Ltd. Imorphics was initially a spin out from the world renowned Computer Imaging Department of Manchester University. Its product, EndPoint, is a software environment in which the user can build and use statistical models, as well as view images and perform analysis tasks, such as manual segmentation.
buyer: Stryker Corporation (SYK:$10,062.00)
Stryker Corporation is one of the world's leading medical technology companies with the most broadly based range of products in orthopaedics and a significant presence in other medical specialties. "
 target: imorphics
Imorphics, Ltd. provides medical image analysis software tools. Its projects include work on diseases of the musculoskeletal system, the central nervous system, and oncology. The company’s technology is used in clinical trials, and in both clinical and animal research projects.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/29/2020 via Company Press Release

Ziehm Imaging, acquired THERENVA

See 963 Comparable Transactions
synopsis: Germany-based Ziehm Imaging, a developer of mobile X-ray imaging solutions, has acquired Therenva, a leading French developer of planning and imaging software tools for cardiovascular procedures. Ziehm Imaging will leverage its strong distribution network of mobile C-arms to market Therenva’s current product portfolio globally.
buyer: Ziehm Imaging
Germany-based Ziehm Imaging specializes in the development, manufacturing, and worldwide marketing of mobile X-ray-based imaging solutions. The company is the recognized innovation leader in the mobile C-arm industry and a market leader in Germany and other European countries. "
 target: THERENVA
France-based Therenva designs the most advanced and user-friendly imaging software toolset for cardiovascular procedures. The unique EndoSize 3D case planning software has become an essential tool in the daily practice of many physicians and healthcare professionals.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/20/2019 via BNC Analysis

Circle Cardiovascular Imaging Inc., acquired Corstem

See 1011 Comparable Transactions
synopsis: Circle Cardiovascular Imaging, a Canadian developer of analytical software for the cardiac imaging community, has acquired Corstem, a Montreal-based machine learning and artificial intelligence software developer focused on cardiac imaging analysis. Corstem offers a suite of solutions that enables better, safer, and faster care decision.​
buyer: Circle Cardiovascular Imaging Inc.
Circle Cardiovascular Imaging is a Canadian developer of analytical software for the cardiac imaging community. Circle's product suite, civ42, is engineered for use in cardiac imaging and has been designed specifically to facilitate efficient quantitative evaluation of cardiac imaging studies. "
 target: Corstem
Corstem is a Montreal-based machine learning and artificial intelligence software developer focused on cardiac imaging analysis. Corstem offers a suite of solutions that enables a whole new level of efficiency and automation for diagnosis aid to achieve better, safer, and faster care decision.​
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 6/6/2018 via BNC Analysis

Philips Electronics NV, will acquire EPD Solutions Ltd.

See 966 Comparable Transactions
synopsis: Royal Philips, a global leader in health technology, will acquire EPD Solutions from the Hobart Group, an international portfolio of medical device companies. EPD specializes in making cardiac imaging and navigation systems that help electrophysiologists navigate the heart by generating a detailed 3D image of the cardiac anatomy.
buyer: Philips Electronics NV (ENXTAM:PHIA:$23,759.43)
Based in the Netherlands, Philips is a leading health technology company focused on improving people’s health and enabling better outcomes across the health continuum. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. "
 target parent: Hobart Group (Medical Device)
target: EPD Solutions Ltd.
EPD Solutions (EPD) is dedicated to improving the efficiency of minimally invasive catheter-based procedures performed to treat cardiac arrhythmias. EPD's cardiac imaging and navigation system helps electrophysiologists navigate the heart by generating a detailed 3D image of the cardiac anatomy.
price ($mm)
$292
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/15/2017 via PE Hub

Imagia, acquired Cadens Medical Imaging

See 963 Comparable Transactions
synopsis: Imagia, a Montreal-based healthcare artificial intelligence (AI) company developing radiomics biomarkers and clinical decision support systems, announced the completion of its acquisition of Cadens Medical Imaging (Cadens), a technology leader in medical imaging software.
buyer: Imagia
Imagia is a Montreal-based healthcare artificial intelligence (AI) company developing radiomics biomarkers and clinical decision support systems. "
 target: Cadens Medical Imaging
Cadens Medical Imaging (Cadens) is a technology leader in medical imaging software. Since 2008, Cadens has developed and marketed FDA and CE cleared innovative medical imaging software products for cancer care.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/13/2015 via BusinessWire

Toshiba Medical Systems Corporation, acquired Olea Medical

See 960 Comparable Transactions
synopsis: Olea Medical SA, a company that designs and markets innovative medical imaging applications, has been acquired by Toshiba Medical Systems Corporation, a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions.
buyer parent: Toshiba
buyer: Toshiba Medical Systems Corporation
Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultrasound, nuclear medicine, and MRI systems, as well as information systems for medical institutions. "
 target: Olea Medical
Olea Medical™ designs and markets innovative medical imaging applications that significantly improve diagnostic processes and treatment evaluation. They are based in France.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 11/4/2014 via Company Press Release

MedImmunie, Inc., will acquire Definiens

See 963 Comparable Transactions
synopsis: AstraZeneca announced that MedImmune, its global biologics research and development arm, has entered into an agreement to acquire Definiens, a privately-held company that has pioneered a world-leading imaging and data analysis technology, known as Tissue Phenomics, which dramatically improves the identification of biomarkers in tumour tissue.
buyer parent: AstraZeneca
buyer: MedImmunie, Inc.
MedImmune is pioneering innovative research and exploring novel pathways across key therapeutic areas, including respiratory, inflammation and autoimmunity; cardiovascular and metabolic disease; oncology; neuroscience; and infection and vaccines. "
 target: Definiens
Definiens is the leading provider of image analysis and data mining solutions for tissue diagnostics and clinical digital pathology. Definiens technology provides detailed cell-by-cell readouts from target structures on tissue slides.
price ($mm)
$150
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/20/2021 via GlobeNewswire

SeaSpine, acquired 7D Surgical

See 963 Comparable Transactions
synopsis: SeaSpine, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, has acquired 7D Surgical, a privately-owned Toronto based company that develops advanced optical technologies and machine vision-based registration algorithms to improve surgical workflow and patient care.
buyer: SeaSpine (SPNE:$160.19)
SeaSpine is a global medical technology company focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. "
 target: 7D Surgical
7D Surgical is a privately-owned Toronto based company that develops advanced optical technologies and machine vision-based registration algorithms to improve surgical workflow and patient care.
price ($mm)
$110
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/25/2016 via Company Press Release

Vela Diagnostics Pte. Ltd., purchased Data Interpretation Division from Lifecode, Inc.

See 1014 Comparable Transactions
synopsis: Vela Diagnostics announced that it has acquired the data interpretation division of Lifecode Inc., a Foster City, California-based cancer molecular company. The data interpretation products and services from Lifecode will be connected to Vela Diagnostics’ Next-Generation Sequencing Sentosa® SQ Reporter Software.
buyer: Vela Diagnostics Pte. Ltd.
Vela Diagnostics is a worldwide supplier of integrated life sciences and diagnostic solutions that help provide customers with valuable molecular information. It delivers innovative technology and products* that address many of the clinical, technical and economic issues facing laboratories. "
 seller: Lifecode, Inc.
Lifecode Inc’s data interpretation service provides access to Lifecode’s data integration framework, interpretation and report generation pipelines. Lifecode is a specialized CLIA certified clinical laboratory focused on the genetic basis of human disease.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/1/2012 via PR Web

Visualization Sciences Group, acquired Amira

See 967 Comparable Transactions
synopsis: Visage Imaging, Inc. announced they have signed a definitive agreement completing the sale of the Amira Division to Visualization Sciences Group. Amira is a powerful, multifaceted software platform for visualizing, manipulating, and understanding Life Science and bio-medical data coming from all types of sources and modalities.
buyer parent: FEI
buyer: Visualization Sciences Group
Visualization Sciences Group is the leading provider of high-performance 3D visualization toolkits and software for engineers and scientists, delivering advanced 3D software solutions for scientific data visualization, engineering and simulation, materials science and geosciences. "
 target parent: Pro Medicus
target: Amira
Amira is a powerful, multifaceted software platform for visualizing, manipulating, and understanding Life Science and bio-medical data coming from all types of sources and modalities.
price ($mm)
$15
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/10/2014 via PR Newswire

Alphaeon Corporation, acquired TouchMD

See 1084 Comparable Transactions
synopsis: ALPHAEON Corporation, a subsidiary of Strathspey Crown Holdings LLC, announced that it has acquired TouchMD. TouchMD is an interactive software platform that helps specialty physicians educate patients before, during and after practice consultation, which enhances the patient experience and increases conversion rates.
buyer parent: Strathspey Crown
buyer: Alphaeon Corporation
Alphaeon Corporation is a lifestyle healthcare company committed to partnering with board-certified physicians to bring to market and develop highly innovative technologies and services that promote patient wellness, beauty and performance. "
 target: TouchMD
TouchMD is an interactive software platform that helps specialty physicians educate patients before, during and after practice consultation, which enhances the patient experience and increases conversion rates. They offer product lines in Plastics, OBGYN, Dermatology, and Orthopedics.
price ($mm)
$22
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/9/2020 via BusinessWire

RapidAI, acquired Endovantage, LLC

See 554 Comparable Transactions
synopsis: RapidAI, the worldwide leader in advanced imaging for stroke, announced the acquisition of EndoVantage, developer of the Find, Track and Treat™ comprehensive cerebral aneurysm management platform. EndoVantage provides clinicians with novel computational tools for the personalized planning of endovascular treatments.
buyer: RapidAI
RapidAI is the worldwide leader in advanced imaging for stroke. Installed in over 1,500 hospitals in more than 50 countries, the Rapid imaging platform, powered by artificial intelligence, includes Rapid CTP, Rapid MRI, Rapid CTA, Rapid ICH, and Rapid ASPECTS*. "
 target: Endovantage, LLC
EndoVantage is the developer of the Find, Track and Treat™ comprehensive cerebral aneurysm management platform. EndoVantage provides clinicians with novel computational tools for the personalized planning of endovascular treatments.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/9/2020 via BusinessWire

Riverside Insights, acquired ImPACT Concussion Management

See 1040 Comparable Transactions
synopsis: Riverside Insights, a provider of educational and clinical assessments and a portfolio company of Alpine Investors, has acquired ImPACT Applications, Inc., a leading provider of research-backed concussion assessments. ImPACT Applications offers the only FDA-cleared neurocognitive evaluation aid with concussion specific indications for ages 12-59.
buyer parent: Alpine Investors, LP
buyer: Riverside Insights
Riverside is a provider of educational and clinical assessments that play a key role in helping individuals elevate their learning potential by providing accurate and reliable data. Riverside is comprised of several iconic, leading brands such as Woodcock-Johnson, the Iowa Assessments, and CogAT. "
 target: ImPACT Concussion Management
ImPACT Applications, Inc. is the maker of ImPACT, ImPACT Pediatric, and ImPACT Quick Test, all FDA cleared Class I & II medical devices and software solutions that assist in the screening, assessment, and management of concussion.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/24/2017 via BNC Analysis

ERT, acquired ImageIQ

See 1008 Comparable Transactions
synopsis: ERT - a provider of clinical trial services - announced the acquisition of ImageIQ, an imaging software and contract research organization and software developer for customized imaging and analysis.
buyer parent: Nordic Capital
buyer: ERT
ERT is a leading provider of high-quality patient data collection solutions for use in clinical drug development. ERT delivers a combination of technology, services and clinical consulting that increase the accuracy and reliability of patient data and improve the widely deployed solutions. "
 target: ImageIQ
ImageIQ is an imaging software and contract research organization and software developer for customized imaging and analysis.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 1/27/2016 via BNC Analysis

Venaxis, Inc., will acquire Strand Life Sciences

See 1072 Comparable Transactions
synopsis: Venaxis, a developer of an in vitro diagnostic test for acute appendicitis, is to acquire Strand Life Sciences, a cancer genomics firm. Strand's entry into healthcare was through software products and services that combine advanced visualization, systems modeling, and scientific insights for enabling biological and health sciences research.
buyer: Venaxis, Inc. (BIOP:$0.01)
Venaxis is a Colorado-based in vitro diagnostic company focused on developing and commercializing its unique multi-biomarker diagnostic test, the APPY1™ Test, which is designed to aid in the identification of patients at low risk for acute appendicitis. "
 target: Strand Life Sciences
Strand's entry into healthcare was through software products and services that combine advanced visualization, systems modeling, and scientific insights for enabling biological and health sciences research.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/21/2014 via Company Press Release

Materialise Dental N.V., acquired OrthoView

See 936 Comparable Transactions
synopsis: Materialise announced the acquisition of UK-based OrthoView Holdings Limited, the world's leading provider of 2D digital pre-operative planning and templating solutions for orthopedic surgeons. OrthoView’s software imports a digital X-ray image from a PACS and positions the templates of suitable prostheses on the X-ray image at the correct scale.
buyer: Materialise Dental N.V. (GS:MTLS:$86.16)
Materialise Dental offers planning and simulation software tools under the SimPlant brand. These tools enable implantologists and oral surgeons to scientifically plan dental implant surgery on an interactive basis. "
 target: OrthoView
OrthoView enables orthopedists to create detailed pre-operative plans quickly and easily from digital x-ray images. The OrthoView solution provides an easy to use method of planning and templating with digital x-ray images, incorporating specialist on-screen measuring tools and patented wizards.
price ($mm)
$14
rev ($mm)
$6
EBITDA ($mm)
$2
EV / rev
2.6x
EV / EBITDA
9.3x
closed 12/27/2007 via BNC Analysis

Marine Park Holdings, Inc., merged with NewCardio, Inc.

See 1038 Comparable Transactions
synopsis: NewCardio, Inc. announced the closing of a share exchange agreement with Marine Park Holdings, Inc. whereby NewCardio is now a public company by way of reverse merger. NewCardio's common stock is currently quoted for trading on the Over the Counter Bulletin Board.
buyer: Marine Park Holdings, Inc.
Marine Park Holdings, Inc. formerly known as: EP Floors, Inc. does not have significant operations. "
 target: NewCardio, Inc.
NewCardio is a Silicon Valley based company with the mission of fully developing and commercializing a three dimensional (3D) approach to electrocardiography.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 9/30/2020 via BNC Analysis

Comet Group, will acquire Object Research Systems, Inc.

See 752 Comparable Transactions
synopsis: The Comet Group, a globally leading Swiss technology firm, will acquire Object Research Systems (ORS), a provider of 3D-visualization and analysis solutions for research and industrial applications in Canada. ORS' Dragonfly platform delivers volume rendering and advanced analysis functions. They also offer a powerful medical imaging solution.
buyer: Comet Group (SWX:COTN:$412.18)
The Comet Group is a globally leading Swiss technology firm. Comet develops and produces innovative high-tech components and systems based on x-ray and radio frequency (RF). The group manufactures RF matching networks, RF generators, x-ray modules, x-ray tubes, x-ray systems, and more. "
 target: Object Research Systems, Inc.
Object Research Systems (ORS) is a provider of 3D-visualization and analysis solutions for research and industrial applications in Canada. ORS' Dragonfly platform delivers state-of-the-art volume rendering and advanced analysis functions. They also offer a powerful medical imaging solution.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 11/27/2019 via Company Press Release

Canon Medical System, will acquire Skope Magnetic Resonance Technologies AG

See 1069 Comparable Transactions
synopsis: Canon Medical Systems, a Japanese subsidiary of Canon that developed and introduced the first Japanese MRI and has been devoting itself to research and development of innovative MRI technologies, has acquired Skope, a Swiss company devoted to providing MRI users with unprecedented imaging quality and performance.
buyer parent: Canon Inc.
buyer: Canon Medical System
Canon Medical Systems developed and introduced the first Japanese MRI in 1983, and has been devoting itself to research and development of innovative MRI technologies such as Pianissimo, Canon Medical’s unique acoustic noise reduction technology, providing extraordinary patient comfort. "
 target: Skope Magnetic Resonance Technologies AG
Skope Magnetic Resonance Technologies AG is a Swiss company devoted to providing MRI users with unprecedented imaging quality and performance. Skope’s expertise in MRI sensorics, signal-processing and image reconstruction covers the entire chain from signal acquisition to image generation
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/14/2018 via BNC Analysis

Flying Brands LTD., acquired Imaging Biometrics

See 1069 Comparable Transactions
synopsis: Flying Brands, a medical services and software company based in the United Kingdom, has acquired Imaging Biometrics, a company based in Wisconsin that is advancing the field of medical imaging by specializing in the design and manufacture of advanced visualization software solutions using quantitative imaging endpoints/biomarkers.
buyer: Flying Brands LTD.
Flying Brands Limited is a medical services and software company based in the United Kingdom. Their product, Stonechecker, is a supplier of technology solutions in the field of kidney stone analysis and kidney stone prevention. "
 target: Imaging Biometrics
Imaging Biometrics (IB) is based in Wisconsin, USA. It is advancing the field of medical imaging by specializing in the design and manufacture of advanced visualization software solutions using quantitative imaging endpoints/biomarkers.
price ($mm)
$0.76
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
Pages:  
closed 2/11/2016 via BNC Analysis

Stryker Corporation, acquired imorphics

See 991 Comparable Transactions
synopsis: Stryker Corporation has acquired Imorphics, Ltd. Imorphics was initially a spin out from the world renowned Computer Imaging Department of Manchester University. Its product, EndPoint, is a software environment in which the user can build and use statistical models, as well as view images and perform analysis tasks, such as manual segmentation.
buyer: Stryker Corporation (SYK:$10,062.00)
Stryker Corporation is one of the world's leading medical technology companies with the most broadly based range of products in orthopaedics and a significant presence in other medical specialties. "
 target: imorphics
Imorphics, Ltd. provides medical image analysis software tools. Its projects include work on diseases of the musculoskeletal system, the central nervous system, and oncology. The company’s technology is used in clinical trials, and in both clinical and animal research projects.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/11/2016 via BNC Analysis

Stryker Corporation, acquired imorphics

See 991 Comparable Transactions
synopsis: Stryker Corporation has acquired Imorphics, Ltd. Imorphics was initially a spin out from the world renowned Computer Imaging Department of Manchester University. Its product, EndPoint, is a software environment in which the user can build and use statistical models, as well as view images and perform analysis tasks, such as manual segmentation.
buyer: Stryker Corporation (SYK:$10,062.00)
Stryker Corporation is one of the world's leading medical technology companies with the most broadly based range of products in orthopaedics and a significant presence in other medical specialties. "
 target: imorphics
Imorphics, Ltd. provides medical image analysis software tools. Its projects include work on diseases of the musculoskeletal system, the central nervous system, and oncology. The company’s technology is used in clinical trials, and in both clinical and animal research projects.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/11/2009 via PR Newswire

Stryker Corporation, acquired OtisMed Corporation

See 1080 Comparable Transactions
synopsis: Stryker Corporation announced that it has acquired OtisMed Corporation, a privately held, software technology firm. OtisMed will focus on customizable instrumentation that has the potential to complement the many benefits that surgeons and patients realize from Stryker's Triathlon Knee System.
buyer: Stryker Corporation (SYK:$10,062.00)
Stryker Corporation is one of the world's leading medical technology companies with the most broadly based range of products in orthopaedics and a significant presence in other medical specialties. "
 target: OtisMed Corporation
Founded in 2005, OtisMed Corporation is a software technology firm dedicated to providing new solutions for complex clinical problems in joint replacement. OtisMed's focus is on developing and commercializing highly accurate, cost-effective, and customized surgical solutions.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/2/2004 via BusinessWire

Apogent Technologies, Inc. merged with Fisher Scientific International Inc.,

See 32 Comparable Transactions
synopsis: Fisher Scientific International Inc. (NYSE: FSH) today completed its approximately $4.0 billion merger with Apogent Technologies Inc. (formerly trading as NYSE: AOT), providing Fisher Scientific with a $1.1 billion footprint in the high-growth life-science market.
buyer parent: Thomas H. Lee Partners, L.P.
buyer: Fisher Scientific International Inc.
Fisher Scientific International, Inc. provides products and services to the scientific research and clinical laboratory markets. It operates in three segments: Scientific Products and Services, Healthcare Products and Services, and Laboratory Workstations. The Scientific Products and Services segmen"
 target: Apogent Technologies, Inc.
Apogent Technologies Inc. is a developer and manufacturer of value-added products for the clinical and research markets. Over 80% of the Company's products are consumables. Apogent's operating subsidiaries manufacture most of their products in approximately 80 facilities worldwide. The Company's cu
price ($mm)
$3,991
rev ($mm)
$1,118
EBITDA ($mm)
$313
EV / rev
3.6x
EV / EBITDA
12.7x
announced 1/13/2020 via GlobeNewswire

TelaDoc, Inc., will acquire InTouch Health

See 1302 Comparable Transactions
synopsis: Teladoc Health, Inc., the global leader in virtual care, will acquire InTouch Health, the leading provider of enterprise telehealth solutions for hospitals and health systems. This acquisition positions Teladoc Health as the partner of choice for health systems seeking a single solution for their entire virtual care strategy.
buyer: TelaDoc, Inc. (TDOC:$716.29)
Teladoc Health is transforming the healthcare experience with a focus on high quality, lower costs, and improved outcomes. Telehealth Satisfaction Study, the integrated services from Teladoc Health include telehealth, expert medical services, AI and analytics, and licensable platform services. "
 target parent: Galen Partners
target: InTouch Health
InTouch Health is a telehealth services company that offers healthcare providers a reliable, dedicated cloud-based network and virtual care solutions to efficiently deliver care for a broad array of use cases and healthcare environments.
price ($mm)
$600
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 3/8/2016 via PR Newswire

Nordic Capital, will acquire ERT

See 58 Comparable Transactions
synopsis: Genstar Capital, a leading private equity firm focused on the healthcare, software, financial services, and industrial technology industries, announced the sale of ERT, a leading provider of high-quality patient data collection solutions for use in clinical drug development, to Nordic Capital Fund VIII.
buyer: Nordic Capital
Nordic Capital is a leader in Nordic private equity investments, and now has an enviable reputation in investment and portfolio management. Since launching in 1989, Nordic Capital funds have delivered outstanding returns for our investors. "
 target parent: Genstar Capital LLC
target: ERT
ERT is a leading provider of high-quality patient data collection solutions for use in clinical drug development. ERT delivers a combination of technology, services and clinical consulting that increase the accuracy and reliability of patient data and improve the widely deployed solutions.
price ($mm)
rev ($mm)
$300
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
closed 7/3/2012 via PR Newswire

Genstar Capital LLC, acquired ERT

See 58 Comparable Transactions
synopsis: ERT, a global technology-driven provider of health outcomes services to biopharmaceutical sponsors and contract research organizations, announced that Genstar Capital, LLC, has completed its acquisition of the company in a take-private transaction.
buyer: Genstar Capital LLC
Genstar Capital LLC has more than $3 billion of committed capital under management and targets investments focused on selected sectors within the life science, healthcare services, software and software services, insurance and financial services, and industrial technology industries. "
 target: ERT
ERT is a global technology-driven provider of health outcomes research services and customizable medical devices supporting biopharmaceutical sponsors and contract research organizations to achieve their drug development and healthcare objectives.
price ($mm)[EV]
$395 [$370]
rev ($mm)
$194
EBITDA ($mm)
$42
EV / rev
1.9x
EV / EBITDA
9.0x
announced 10/27/2009 via Reuters

The Carlyle Group, will acquire Broadleaf Co., Ltd.

See 51 Comparable Transactions
synopsis: Private equity firm The Carlyle Group announced that it has agreed to purchase Broadleaf Co, a Japanese maker of software for car maintenance facilities. This is the first buyout for Carlyle in Japan since it bought LCD glass maker AvanStrate Inc.
buyer: The Carlyle Group (CG:$6,117.50)
The Carlyle Group is a private global investment firm that originates, structures and acts as lead equity investor in management-led buyouts, strategic minority equity investments, equity private placements, consolidations and buildups, and growth capital financings. "
 target parent: Olympus Corporation
target: Broadleaf Co., Ltd.
Broadleaf Co. is involved in the development, sale, and support of various software packages for the automotive industry, including the Super Frontman automobile maintenance system, administrative system packages for inventory control, customer control, and estimate/sales/billing control.
price ($mm)
$212
rev ($mm)
$181
EBITDA ($mm)
EV / rev
1.2x
EV / EBITDA
closed 9/1/2017 via BusinessWire

Clayton, Dubilier & Rice, Inc., Hillhouse Capital, acquired Carestream Dental

See 1827 Comparable Transactions
synopsis: Carestream Health, working with its parent company, Onex Corporation, has completed the sale of Carestream’s dental digital business to funds managed by Clayton, Dubilier & Rice, a global private investment firm, and CareCapital, a specialist investment platform focused on dental and consumer health in Asia and part of Hillhouse Capital Management.
buyer: Clayton, Dubilier & Rice, Inc.
buyer: Hillhouse Capital
Founded in 1978, Clayton, Dubilier & Rice is a private investment firm. Since inception, CD&R has managed the investment of more than $22 billion in 72 companies representing a broad range of industries with an aggregate transaction value of more than $100 billion. "
 target parent: Onex Corporation
target: Carestream Dental
Carestream Dental is the dental digital business of Carestream, an operating company of Onex Corporation. Carestream Dental provides digital imaging equipment and software solutions for dental and oral health professionals. They provide products that are used throughout the world.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/24/2019 via PR Newswire

3B Scientific GmbH, acquired Cardionics

See 1017 Comparable Transactions
synopsis: 3B Scientific, a leading German manufacturer and marketer of anatomical and biological education and simulation products for science, healthcare and patient education, announced the acquisition of Cardionics, a leader in Auscultation Simulation products that integrate seamlessly into classroom, clinical, and telehealth applications.
buyer parent: Whitney & Co. LLC
buyer: 3B Scientific GmbH
Headquartered in Germany, 3B Scientific is the world's leading manufacturer of anatomical and biological education and simulation for science, healthcare and patient education. Represented in over 100 countries worldwide, 3B Scientific stands for best quality, best value, and best service. "
 target: Cardionics
Cardionics continues to set the pace for auscultation products and services through the development of unique, interactive, and experiential systems that integrate seamlessly into classroom, clinical, and telehealth applications.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 8/5/2020 via GlobeNewswire

Livongo will be merged with TelaDoc, Inc.,

See 82 Comparable Transactions
synopsis: Teladoc Health, the global leader in virtual care, and Livongo, the leading Applied Health Signals company, have entered into a definitive merger agreement. The combination of Teladoc Health and Livongo will create a global leader in consumer centered virtual care. The combined company will operate under the Teladoc Health brand.
buyer: TelaDoc, Inc. (TDOC:$716.29)
Teladoc Health is recognized as the world leader in virtual care. They deliver millions of medical visits across 175 countries annually through the Teladoc Health Medical Group, enabling millions of patient and provider touchpoints for hospitals, health systems, and physician practices globally. "
 target: Livongo (LVGO:$257.96)
Livongo empowers people with chronic conditions to live better and healthier lives. Using its AI+AI engine, Livongo aggregates and interprets health data and information to create actionable, personalized, and timely health signals delivered to Livongo Members exactly when and where they need them.
price ($mm)[EV]
$16,988 [$16,567]
rev ($mm)
$258
EBITDA ($mm)
EV / rev
70.8x
EV / EBITDA
announced 6/3/2020 via BusinessWire

BreathResearch will be merged with AireHealth,

See 794 Comparable Transactions
synopsis: AireHealth Inc., a company that offers affordable treatments, symptom tracking and early detection of respiratory conditions, has reached a merger agreement with BreathResearch, a respiratory healthcare company that detects increasing declines in respiratory health status.
buyer: AireHealth
AireHealth offers affordable treatments, symptom tracking and early detection of respiratory conditions. The company provides monitored drug delivery via its FDA cleared Class 2 portable nebulizer, designed to deliver medicine directly to a patient’s lungs where it is most effective. "
 target: BreathResearch
BreathResearch is an innovative healthcare company that offers a solution that converts the air waves from breathing into sound waves producing new respiratory analytics to improve health, fitness and performance.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/9/2020 via BusinessWire

Riverside Insights, acquired ImPACT Concussion Management

See 1040 Comparable Transactions
synopsis: Riverside Insights, a provider of educational and clinical assessments and a portfolio company of Alpine Investors, has acquired ImPACT Applications, Inc., a leading provider of research-backed concussion assessments. ImPACT Applications offers the only FDA-cleared neurocognitive evaluation aid with concussion specific indications for ages 12-59.
buyer parent: Alpine Investors, LP
buyer: Riverside Insights
Riverside is a provider of educational and clinical assessments that play a key role in helping individuals elevate their learning potential by providing accurate and reliable data. Riverside is comprised of several iconic, leading brands such as Woodcock-Johnson, the Iowa Assessments, and CogAT. "
 target: ImPACT Concussion Management
ImPACT Applications, Inc. is the maker of ImPACT, ImPACT Pediatric, and ImPACT Quick Test, all FDA cleared Class I & II medical devices and software solutions that assist in the screening, assessment, and management of concussion.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/14/2018 via BNC Analysis

MindMaze, acquired Neuro Motor Innovations Corporation

See 487 Comparable Transactions
synopsis: MindMaze, operator of a platform that captures brain activity announced its acquisition of fellow neuro-rehabilitation tech company Neuro Motor Innovations Corporation (NMI). NMI is a medical technology company with a mission to improve movement and cognition outcomes through their brain repair therapy.
buyer: MindMaze
MindMaze operates a platform that captures brain activity, creating a new operating system for computers - a brain O/S. They designed an intuitive mind/machine interface, which utilizes pre-realtime decoding of brain signals via neural prediction, transforming healthcare and gaming industries. "
 target: Neuro Motor Innovations Corporation
Neuro Motor Innovations (NMI) is a medical technology company with a mission to improve movement and cognition outcomes in aging and neurology patients. NMI’s solution includes a proprietary medical gaming platform, game therapy software, and hardware control devices for hand, arm, foot and face.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/1/2016 via GlobeNewswire

BioTelemetry, acquired Telcare

See 8 Comparable Transactions
synopsis: BioTelemetry, Inc. is pleased to announce the acquisition of Telcare. Telcare is a leading digital-health company whose pioneering work includes development of the first FDA-cleared cellular enabled blood glucometer and cloud-based diabetes data repository system.
buyer: BioTelemetry (BEAT:$386.46)
BioTelemetry, Inc. is the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care. The company currently provides cardiac monitoring services, original equipment manufacturing and more. "
 target: Telcare
Telcare is a leading digital-health company whose pioneering work includes development of the first FDA-cleared cellular enabled blood glucometer and cloud-based diabetes data repository system.
price ($mm)
$7.00
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/24/2019 via BusinessWire

ZOLL Medical Corporation, acquired Mobilize RRS LLC

See 35 Comparable Transactions
synopsis: ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, has acquired Mobilize RRS LLC., a company that markets the Mobilize Rescue Systems app and associated rescue kits. Each Mobilize Rescue Systems product contains medical equipment that pairs with interactive software to help bystanders manage emergencies.
buyer parent: Asahi Kasei Group
buyer: ZOLL Medical Corporation
ZOLL Medical Corporation, an Asahi Kasei Group company, develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. "
 target: Mobilize RRS LLC
Mobilize RRS equips bystanders with the resources necessary to respond to medical emergencies. Mobilize RRS’ team of medical professionals, military veterans, and software developers integrated modern medical supplies and an innovative app into a cohesive unit, as Mobilize Rescue Systems.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/13/2020 via Company Press Release

Medtronic, Inc., acquired Digital Surgery

See 898 Comparable Transactions
synopsis: Medtronic, the global leader in medical technology, announced the acquisition of Digital Surgery, a privately-held pioneer in surgical artificial intelligence (AI), data and analytics, and digital education and training.
buyer: Medtronic, Inc. (MDT:$31,062.00)
Medtronic is among the world’s largest medical technology, services and solutions companies, alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 90,000 people worldwide, serving physicians, hospitals and patients. "
 target: Digital Surgery
Headquartered in London, England, Digital Surgery’s mission is to digitize surgical protocols using cutting-edge computing and to support the delivery of consistent, data-driven and evidence-based surgical care.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/23/2018 via BusinessWire

TransEnterix, Inc., acquired MST Medical Surgery Technologies Ltd.

See 1006 Comparable Transactions
synopsis: TransEnterix, a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, has acquired MST Medical Surgery Technologies Ltd. (MST), an Israel medical technology company. MST develops advanced image analysis software to empower and automate the surgical environment.
buyer: TransEnterix, Inc. (AMEX:TRXC:$14.74)
TransEnterix is a medical device company that is pioneering the use of robotics to improve minimally invasive surgery. Their Senhance Surgical Robotic System is a multi-port robotic system that brings the advantages of robotic surgery to patients while enabling surgeons with innovative technology. "
 target: MST Medical Surgery Technologies Ltd.
MST Medical Surgery Technologies Ltd. (MST) is an Israel medical technology company. MST develops advanced image analysis software to empower and automate the surgical environment, with a focus on medical robotics and computer-assisted surgery (MRCAS).
price ($mm)
$33
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 3/6/2012 via PR Newswire

CareFusion Corporation, will acquire PhACTs, LLC.

See 661 Comparable Transactions
synopsis: CareFusion Corporation announced an agreement to acquire PHACTS, LLC, a Seattle-based technology and consulting company that helps hospital pharmacies better manage inventory, reduce pharmaceutical costs and streamline operations. Terms of the deal were not disclosed.
buyer: CareFusion Corporation (CFN:$3,598.00)
CareFusion Corporation is a global corporation serving the health care industry with products and services that help hospitals measurably improve the safety and quality of care. "
 target: PhACTs, LLC.
PHACTS was formed to serve Health Systems with multiple hospitals and/or clinics, doctors' offices, surgery centers and other locations, which need to account for and provide medications and pharmacy supplies across their network.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/15/2019 via BusinessWire

Tactical Medical Solutions, Inc., acquired TraumaFX

See 172 Comparable Transactions
synopsis: Tactical Medical Solutions has acquired TraumaFX Solutions, Inc., a company that is dedicated to developing innovative medical simulation and training technologies that improve survivability of severe injuries on the battlefield and in civilian casualty situations.
buyer parent: Guardian Capital Partners
buyer: Tactical Medical Solutions, Inc.
Tactical Medical Solutions, LLC (TacMed) is a global leader in the development and manufacture of innovative, proprietary pre-hospital medical products and technologies that serve a full spectrum of emergency response environments. "
 target parent: ManTech International Corporation
target: TraumaFX
TraumaFX is dedicated to developing innovative medical simulation and training technologies that improve survivability of severe injuries on the battlefield and in civilian casualty situations.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 8/31/2015 via PR Newswire

Nuvon, Inc. will be merged with Bernoulli Enterprise, Inc.,

See 697 Comparable Transactions
synopsis: Cardiopulmonary Corp., a leader in real-time connected healthcare and Nuvon, a leader in medical device integration, interoperability, and clinical intelligence, announced that they have entered into a definitive agreement for Nuvon to merge with Cardiopulmonary Corp.
buyer: Bernoulli Enterprise, Inc.
Cardiopulmonary Corp. is a leader in real-time connected healthcare. Its flagship Bernoulli Enterprise system provides a platform for Medical Device Connectivity, Alarm Management, Virtual ICU and Analytics to enable better outcomes, reduce the cost of care and improve patient/staff satisfaction. "
 target: Nuvon, Inc.
Nuvon's mission is to transform medicine by delivering critical Patient Care Data at the point of care. Nuvon's FDA cleared Class I and Class II Medical Device Connectivity and Clinical Intelligence Systems connect and automates the capture of Patient Care Data from medical devices.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/29/2017 via BNC Analysis

B.Braun Medical Inc., acquired BPMpathway

See 547 Comparable Transactions
synopsis: B. Braun, one of the world’s leading manufacturers of medical devices and pharmaceutical products, has acquired 270 Vision Limited (BPMpathway), a UK-based developer of wearable sensor technology. BPMpathway focuses on innovative wearable medical-grade sensors and advanced body data analysis technology for professional sports and medical sectors.
buyer: B.Braun Medical Inc.
B. Braun is a German medical and pharmaceutical device company, which has offices and facilities in more than 50 countries. Its headquarters are located in the small town of Melsungen, in central Germany. "
 target: BPMpathway
BPMpathway (270 Vision Limited) is a UK-based developer of wearable sensor technology. Product design and development company BPMpathway focuses on innovative wearable medical-grade sensors and advanced body data analysis technology for professional sports and medical sectors.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/14/2013 via Market Watch

Medtronic, Inc., acquired CardioCom

See 1229 Comparable Transactions
synopsis: Medtronic, Inc., the global leader in medical technology, announced the closing of the acquisition of Cardiocom, a privately held developer and provider of integrated telehealth and patient services for the management of chronic diseases, in an all cash transaction valued at $200 million.
buyer: Medtronic, Inc. (MDT:$31,062.00)
Medtronic develops and manufactures a wide range of products and therapies with emphasis on providing a complete continuum of care to diagnose, prevent and monitor chronic conditions. "
 target: CardioCom
Cardiocom is a proven leader in Integrated Clinical Telehealth Services. Cardiocom is a world-class developer, manufacturer and clinical telehealth solutions provider with cutting-edge, yet user-friendly telemonitoring products and services.
price ($mm)
$200
rev ($mm)
$50
EBITDA ($mm)
EV / rev
4.0x
EV / EBITDA
Pages:  

Like imorphics


read more

imorphics

THERENVA

Corstem

EPD Solutions Ltd.

Cadens Medical Imaging

Olea Medical

Definiens

7D Surgical

Lifecode, Inc.

Amira

TouchMD

Endovantage, LLC

ImPACT Concussion Management

ImageIQ

Strand Life Sciences

OrthoView

NewCardio, Inc.

Object Research Systems, Inc.

Skope Magnetic Resonance Technologies AG

Imaging Biometrics

Pages:  
read more

imorphics

read more

imorphics

OtisMed Corporation

read more

Apogent Technologies, Inc.

InTouch Health

ERT

ERT

Broadleaf Co., Ltd.

Carestream Dental

Cardionics

Livongo

BreathResearch

ImPACT Concussion Management

Neuro Motor Innovations Corporation

Telcare

Mobilize RRS LLC

Digital Surgery

MST Medical Surgery Technologies Ltd.

PhACTs, LLC.

TraumaFX

Nuvon, Inc.

BPMpathway

CardioCom

Pages:  
Geography
Matching Companies
Ticker: STO:SECTB
 
 
 
 
 
 
 
 
Sectra AB
Sectra AB
Sectra successfully develops and sells cutting edge solutions and services within the niches medical IT and secure communication. The company’s products are used by customers in 50 countries and sales are conducted directly by Sectra as well as through regional partners.
year
2015
rev ($mm)
$121.11
EBITDA ($mm)
$19.82
EBIT ($mm)
$16.26
Net Income ($mm)
$13.69
Employees
603
  • drill down
  • watch
Ticker: VAR
 
 
 
 
 
 
 
 
Varian Medical Systems, Inc.
Varian Medical Systems, Inc.
Varain Medical Systems produces tools that harness the power of X-ray energy to benefit humankind. They have made developments in the fields of radiotherapy, radiosurgery, X-ray tube technology, digital image detectors, cargo screening, and non-destructive testing.
year
2018
rev ($mm)
$2,888.20
EBITDA ($mm)
$597.60
EBIT ($mm)
$525.70
Net Income ($mm)
$143.20
Employees
6600
  • drill down
  • watch
Ticker: GS:MTLS
 
 
 
 
 
 
 
 
Materialise Dental N.V.
Materialise Dental N.V.
Materialise Dental offers planning and simulation software tools under the SimPlant brand. These tools enable implantologists and oral surgeons to scientifically plan dental implant surgery on an interactive basis.
year
2014
rev ($mm)
$86.16
EBITDA ($mm)
$5.18
EBIT ($mm)
$0.35
Net Income ($mm)
$2.18
Employees
958
  • drill down
  • watch
Ticker: ASX:VHT
 
 
 
 
 
 
 
 
Volpara Solutions
Volpara Solutions
Volpara Health Technologies Limited (VHT) is a New Zealand MedTech Software as a Service company. VHT is a leading provider of breast imaging analytics products that improve clinical decision-making and the early detection of breast cancer. Volpara Solutions is the sales and marketing arm of VHT.
year
2019
rev ($mm)
$3.29
EBITDA ($mm)
($7.96)
EBIT ($mm)
($8.08)
Net Income ($mm)
Employees
53
  • drill down
  • watch
Ticker: OB:CSAM
 
 
 
 
 
 
 
 
CSAM Health AS
CSAM Health AS
CSAM is a leading Norwegian company in the specialized eHealth market with a unique blend of best in class innovative technology, and outstanding human skills. Their diverse portfolio of software solutions enables healthcare providers to access relevant clinical information at the point of care.
year
2021
rev ($mm)
$30.36
EBITDA ($mm)
$5.22
EBIT ($mm)
$2.50
Net Income ($mm)
Employees
225
  • drill down
  • watch
Ticker: NMXS
 
 
 
 
 
 
 
 
Net Medical Xpress Solutions, Inc.
Net Medical Xpress Solutions, Inc.
Net Medical Xpress is a medical services company that provides clinical and diagnostic programs using advanced telemedicine solutions for hospitals. The company also develops FDA 510k-cleared and all-inclusive PACS products within the preventative, comprehensive, and critical healthcare segments.
year
2011
rev ($mm)
$3.21
EBITDA ($mm)
($0.20)
EBIT ($mm)
($0.21)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: TSE:4543
 
 
 
 
 
 
 
 
Terumo Corporation
Terumo Corporation
Terumo is a global leader in medical technology. The company's business portfolio ranges from vascular intervention and cardio-surgical solutions, blood transfusion and cell therapy technology, to medical products essential for daily clinical practice such as transfusion systems and diabetes care.
year
2020
rev ($mm)
$5,694.98
EBITDA ($mm)
$1,437.51
EBIT ($mm)
$927.04
Net Income ($mm)
$721.22
Employees
26438
  • drill down
  • watch
Ticker: DXCM
 
 
 
 
 
 
 
 
Dexcom, Inc.
Dexcom, Inc.
DexCom, Inc., headquartered in San Diego, CA, is dedicated to helping people better manage their diabetes by developing and marketing continuous glucose monitoring (CGM) systems for use by people with diabetes and healthcare providers.
year
2018
rev ($mm)
$832.50
EBITDA ($mm)
($2.90)
EBIT ($mm)
($24.10)
Net Income ($mm)
Employees
2290
  • drill down
  • watch
Ticker: CERN
 
 
 
 
 
 
 
 
Cerner Corporation
Cerner Corporation
Cerner's health information technologies connect people, information, and systems. Cerner solutions assist clinicians in making care decisions and enable organizations to manage the health of populations.
year
2020
rev ($mm)
$5,552.99
EBITDA ($mm)
$1,247.29
EBIT ($mm)
$792.06
Net Income ($mm)
$792.91
Employees
27400
  • drill down
  • watch
Ticker: 300253
 
 
 
 
 
 
 
 
Shanghai Kingstar Winning Software Co., Ltd.
Shanghai Kingstar Winning Software is principally engaged in the development of medical software, the provision of technology services and the distribution of hardware products. They primarily offer software, including hospital information systems and public health information management systems.
year
2015
rev ($mm)
$98.42
EBITDA ($mm)
$14.01
EBIT ($mm)
$12.72
Net Income ($mm)
$21.57
Employees
454
  • drill down
  • watch
Ticker: OM:RTC
 
 
 
 
 
 
 
 
Rethinking Care AB
Rethinking Care AB
Rethinking Care introduces a holistic concept in nursing & health, based on 3 interacting spheres of activity - "Software as a service", "Care as a service" & "Health as a service", based on a high level of competence in nursing & healthcare services as well as IT tools developed for health care.
year
2016
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: KOSDAQ:A263700
 
 
 
 
 
 
 
 
Carelabs Co., Ltd.
Carelabs Co., Ltd.
Carelabs is a South Korea-based digital beauty and healthcare company. CareLabs provides comprehensive healthcare IT services, including clinic information services, clinic customer management software, and digital marketing solutions.
year
2019
rev ($mm)
$49.51
EBITDA ($mm)
$4.38
EBIT ($mm)
$3.14
Net Income ($mm)
$1.79
Employees
0
  • drill down
  • watch
Ticker: ICAD
 
 
 
 
 
 
 
 
iCAD, Inc.
iCAD, Inc.
iCAD delivers innovative cancer detection and radiation therapy solutions and services that enable clinicians to find and treat cancers earlier and faster. iCAD offers a range of computer aided detection (CAD) solutions to support rapid detection of breast, prostate and colorectal cancers.
year
2015
rev ($mm)
$47.24
EBITDA ($mm)
$5.53
EBIT ($mm)
$1.33
Net Income ($mm)
Employees
143
  • drill down
  • watch
Ticker: OM:EKTA B
 
 
 
 
 
 
 
 
Elekta AB
Elekta AB
Elekta is pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops state-of-the-art tools and treatment-planning systems for radiation therapy, as well as workflow-enhancing software systems across the spectrum of cancer care.
year
2020
rev ($mm)
$1,523.59
EBITDA ($mm)
$230.61
EBIT ($mm)
$200.20
Net Income ($mm)
$125.79
Employees
4000
  • drill down
  • watch
Ticker: MDRX
 
 
 
 
 
 
 
 
Allscripts
Allscripts
Allscripts is the leading provider of clinical software, connectivity and information solutions that physicians use to improve healthcare. The company's unique solutions inform, connect and transform healthcare, delivering improved care at lower cost.
year
2020
rev ($mm)
$1,718.10
EBITDA ($mm)
$70.02
EBIT ($mm)
($3.04)
Net Income ($mm)
Employees
9600
  • drill down
  • watch
Ticker: SYK
 
 
 
 
 
 
 
 
Stryker Corporation
Stryker Corporation
Stryker Corporation is one of the world's leading medical technology companies with the most broadly based range of products in orthopaedics and a significant presence in other medical specialties.
year
2016
rev ($mm)
$10,062.00
EBITDA ($mm)
$2,717.00
EBIT ($mm)
$2,312.00
Net Income ($mm)
$1,617.00
Employees
27000
  • drill down
  • watch
Ticker: ZBH
 
 
 
 
 
 
 
 
Zimmer Biomet Holdings, Inc.
Zimmer Biomet Holdings, Inc.
Zimmer Biomet is a global leader in musculoskeletal healthcare. They design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products, bone healing, dental implants; and related surgical products.
year
2016
rev ($mm)
$7,604.40
EBITDA ($mm)
$2,722.40
EBIT ($mm)
$1,650.80
Net Income ($mm)
$363.30
Employees
17500
  • drill down
  • watch
Ticker: LSE:SN
 
 
 
 
 
 
 
 
Smith & Nephew, Inc.
Smith & Nephew, Inc.
Smith & Nephew is a global medical technology business. With leadership positions in Orthopaedic Reconstruction, Advanced Wound Management, Sports Medicine and Trauma & Extremities, Smith & Nephew has around 14,000 employees and a presence in more than 100 countries.
year
2019
rev ($mm)
$5,138.00
EBITDA ($mm)
$1,358.00
EBIT ($mm)
$955.00
Net Income ($mm)
$600.00
Employees
17500
  • drill down
  • watch
Ticker: GMED
 
 
 
 
 
 
 
 
Globus Medical
Globus Medical
Globus Medical, Inc. is a leading medical device manufacturer and is driving significant technological advancements across a complete suite of spinal products.
year
2018
rev ($mm)
$675.57
EBITDA ($mm)
$214.47
EBIT ($mm)
$176.10
Net Income ($mm)
$134.48
Employees
1500
  • drill down
  • watch
Ticker: ABT
 
 
 
 
 
 
 
 
Abbott Laboratories
Abbott Laboratories
Abbott Laboratories is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics.
year
2021
rev ($mm)
$37,338.00
EBITDA ($mm)
$10,357.00
EBIT ($mm)
$6,924.00
Net Income ($mm)
$5,724.00
Employees
109000
  • drill down
  • watch
Ticker: BDX
 
 
 
 
 
 
 
 
Becton, Dickinson and Company
Becton, Dickinson and Company
Becton, Dickinson and Company (BD) is a leading medical technology company. BD’s innovative solutions are focused on improving drug delivery, enhancing the diagnosis of infectious diseases and cancers, supporting the management of diabetes and advancing cellular research.
year
2021
rev ($mm)
$19,897.00
EBITDA ($mm)
$5,899.00
EBIT ($mm)
$3,665.00
Net Income ($mm)
$1,955.00
Employees
72000
  • drill down
  • watch
Ticker: MDT
 
 
 
 
 
 
 
 
Medtronic, Inc.
Medtronic, Inc.
Medtronic develops and manufactures a wide range of products and therapies with emphasis on providing a complete continuum of care to diagnose, prevent and monitor chronic conditions.
year
2020
rev ($mm)
$31,062.00
EBITDA ($mm)
$9,558.00
EBIT ($mm)
$7,097.00
Net Income ($mm)
$5,408.00
Employees
90000
  • drill down
  • watch
Ticker: TSE:7733
 
 
 
 
 
 
 
 
Olympus Corporation
Olympus Corporation
Olympus is a global precision technology, designing and delivering innovative solutions in its core business areas of Medical and Surgical Products, Scientific Solutions, and Cameras and Audio Products. Olympus contributes to society every day by making people's lives healthier and safer.
year
2017
rev ($mm)
$6,752.07
EBITDA ($mm)
$1,157.58
EBIT ($mm)
$701.40
Net Income ($mm)
$755.08
Employees
34687
  • drill down
  • watch
Ticker:
 
 
 
 
 
 
 
 
bioMérieux S.A.
bioMérieux S.A.
A world leader in the field of in vitro diagnostics for 50 years, bioMérieux provides diagnostic solutions (reagents, instruments, software) which determine the source of disease and contamination to improve patient health and ensure consumer safety.
year
2015
rev ($mm)
$1,996.55
EBITDA ($mm)
$404.73
EBIT ($mm)
$278.41
Net Income ($mm)
$155.44
Employees
9258
  • drill down
  • watch
Ticker: ENXTPA:DIM
 
 
 
 
 
 
 
 
Sartorius AG
Sartorius AG
Sartorius is a international pharmaceutical and laboratory equipment supplier. With their innovative products and services, they are helping their customers across the entire globe to implement their complex and quality-critical biomanufacturing and laboratory processes reliably and economically.
year
2016
rev ($mm)
$1,121.72
EBITDA ($mm)
$299.20
EBIT ($mm)
$257.20
Net Income ($mm)
$163.92
Employees
4590
  • drill down
  • watch
Ticker: CMD
 
 
 
 
 
 
 
 
Cantel Medical Corp.
Cantel Medical Corp.
Cantel Medical is a leading global company dedicated to delivering innovative infection prevention and control products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives.
year
2018
rev ($mm)
$823.42
EBITDA ($mm)
$159.88
EBIT ($mm)
$127.34
Net Income ($mm)
$89.93
Employees
2337
  • drill down
  • watch
Ticker: MR
 
 
 
 
 
 
 
 
Mindray Medical International Limited
Mindray Medical International Limited
Mindray Medical International Limited is a leading developer, manufacturer and marketer of medical devices worldwide. Mindray maintains global headquarters in Shenzhen, China, U.S. headquarters in Mahwah, New Jersey and multiple sales offices in major international markets.
year
2010
rev ($mm)
$704.31
EBITDA ($mm)
$182.73
EBIT ($mm)
$156.51
Net Income ($mm)
$155.47
Employees
6400
  • drill down
  • watch
Ticker: TNDM
 
 
 
 
 
 
 
 
Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc.
Tandem Diabetes Care is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience. Tandem manufactures and sells the t:slim X2 insulin pump with Control-IQ technology.
year
2020
rev ($mm)
$394.24
EBITDA ($mm)
($12.83)
EBIT ($mm)
($19.30)
Net Income ($mm)
Employees
1043
  • drill down
  • watch
Ticker: NYSE:PEN
 
 
 
 
 
 
 
 
Penumbra, Inc.
Penumbra, Inc.
Penumbra, Inc., headquartered in Alameda, Calif., is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets medical devices and has a broad portfolio of products that addresses challenging medical conditions and significant clinical needs.
year
2018
rev ($mm)
$392.30
EBITDA ($mm)
$24.01
EBIT ($mm)
$18.70
Net Income ($mm)
$28.19
Employees
1700
  • drill down
  • watch
Ticker: XTRA:SBS
 
 
 
 
 
 
 
 
Stratec SE
Stratec SE
STRATEC SE designs and manufactures fully automated analyzer systems for its partners in the fields of clinical diagnostics and biotechnology. Furthermore, the company offers complex consumables for diagnostic and medical applications.
year
2019
rev ($mm)
$240.89
EBITDA ($mm)
$38.57
EBIT ($mm)
$21.94
Net Income ($mm)
$15.69
Employees
1223
  • drill down
  • watch